secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001140361-23-030262
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bionano shareholders approve reverse split authorization; directors elected
---------------------------------------------------------------------------

- Stockholders approved a reverse stock split at a ratio between 1-for-5 and 1-for-10 at board's discretion.
- Proposal 4: 2.064B votes for, 1.077B against, 0.936M abstain (including Series A Preferred votes).
- Elected Class II directors: Albert Luderer, Kristiina Vuori, Hannah Mamuszka for three-year terms.
- Advisory vote on executive compensation passed with 28.96M for, 25.69M against.
- Ratified BDO USA as independent auditor for FY2023 with 123.52M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123030262/0001140361-23-030262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123030262/brhc20054531_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-030262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer